The current financial score of Adapthealth Corp is 6.60. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 740.31M, representing a year-over-year decrease of 7.50%, while its net profit experienced a year-over-year decrease of 1096.57%.
The current valuation score of Adapthealth Corp is 8.93. Its current P/E ratio is -9.79, which is -612.38% below the recent high of 50.15 and -160.97% above the recent low of -25.54.
The current earnings forecast score of Adapthealth Corp is 8.50. The average price target is 9.00, with a high of 10.00 and a low of 7.00.
The current price momentum score of Adapthealth Corp is 4.30. Currently, the stock price is trading between the resistance level at 6.41 and the support level at 5.21, making it suitable for range-bound swing trading.
The current institutional shareholding score of Adapthealth Corp is 10.00. The latest institutional shareholding proportion is 106.67%, representing a quarter-over-quarter decrease of 3.50%. The largest institutional shareholder is James Simons, holding a total of 764.34K shares, representing 0.01% of shares outstanding, with 62.13% increase in holdings.
The current risk assessment score of Adapthealth Corp is 4.29. The company's beta value is 1.49. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.